Phase I/IIB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy and Dose Escalation of RAD001 in Patients With Esophageal Cancer
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Everolimus (Primary) ; Capecitabine; Carboplatin; Cetuximab; Oxaliplatin; Paclitaxel
- Indications Adenocarcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions
- 10 Mar 2018 Planned End Date changed from 1 May 2019 to 1 May 2020.
- 10 Mar 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 06 Jun 2017 Results (n=19) from phase IB portion of the study, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology